AP
ABMD

AHL Partners’s Abiomed Inc ABMD Stock Holding History

AHL Partners’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		$1.84M Buy
9,822
+533
+6% +$99.5K 0.03% 735
2017
Q3 		$1.57M Buy
9,289
+4,133
+80% +$625K 0.03% 746
2017
Q2 		$739K Buy
+5,156
New +$693K 0.02% 866
2016
Q4 		– Sell
-5,436
Closed -$699K – 1222
2016
Q3 		$699K Hold
5,436
– – 0.03% 701
2016
Q2 		$594K Buy
+5,436
New +$541K 0.03% 570

Other funds holding ABMD

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

AHL Partners's ABMD Position: Q4 2017 in Review

AHL Partners increased its Abiomed Inc (ABMD) stake by 5.7% in Q4 2017, buying an estimated $99.5K and bringing the position to 9,822 shares worth $1.84M. The position accounts for 0.03% of the portfolio, ranked #735.

AHL Partners first reported a position in ABMD in Q2 2016 and has held it in 5 quarters since. 361 funds tracked by Wall St. Rank hold ABMD as of Q4 2017.

  • AHL Partners held 9,822 shares of Abiomed Inc worth $1.84M as of Q4 2017.
  • AHL Partners bought 533 Abiomed Inc shares in Q4 2017, an estimated $99.5K.
  • Abiomed Inc made up 0.03% of AHL Partners's portfolio in Q4 2017, its #735 holding.
  • AHL Partners first reported a position in Abiomed Inc in Q2 2016 and has held it in 5 quarters since.
  • 361 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2017.

Based on AHL Partners's 13F filing for Q4 2017, filed 14 Feb 2018.